Sanofi Consumer Healthcare India working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Dec 2025FY25Dec 2024
81.53×81.53×80.22×
9.00×9.00×6.90×
118.89×118.89×137.88×
−28.36×−28.36×−50.76×
2.68×2.40×2.77×
1.80×1.80×1.68×
1.16×1.16×2.43×
0.90×0.90×1.62×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,468.00

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,976 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/09/2026
Inventory Days (DIO)80.2281.5381.53
Receivable Days (DSO)6.909.009.00
Payable Days (DPO)137.88118.89118.89
Cash Conversion Cycle (days)-50.76-28.36-28.36
Working Capital Turnover2.772.402.68
Asset Turnover1.681.801.80
Cash Conversion (CFO/Net Income)2.431.161.16
CFO/EBITDA1.620.900.90
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.